Cephalosporin therapy in intraabdominal infections. A multicenter randomized, comparative study of cefotetan, moxalactam, and cefoxitin - PubMed (original) (raw)
Clinical Trial
Cephalosporin therapy in intraabdominal infections. A multicenter randomized, comparative study of cefotetan, moxalactam, and cefoxitin
S E Wilson et al. Am J Surg. 1988.
Abstract
Three broad-spectrum cephalosporins (cefotetan, moxalactam, and cefoxitin) proved effective in this randomized, prospective trial for treatment of 303 surgical patients with moderately severe regional peritonitis.
Similar articles
- Multicenter clinical trials comparing cefotetan with moxalactam or cefoxitin as therapy for obstetric and gynecologic infections.
Sweet RL, Gall SA, Gibbs RS, Hemsell DL, Knuppel RA, Lane TW, Miller RD, Newton ER, Poindexter AN, Reguero W, et al. Sweet RL, et al. Am J Surg. 1988 May 31;155(5A):56-60. doi: 10.1016/s0002-9610(88)80214-9. Am J Surg. 1988. PMID: 3287970 Clinical Trial. - Cefotetan in the treatment of obstetric and gynecologic infections.
Poindexter AN 3rd, Sweet R, Ritter M. Poindexter AN 3rd, et al. Am J Obstet Gynecol. 1986 Apr;154(4):946-50. doi: 10.1016/0002-9378(86)90495-3. Am J Obstet Gynecol. 1986. PMID: 3515949 Clinical Trial. - Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Ward A, Richards DM. Ward A, et al. Drugs. 1985 Nov;30(5):382-426. doi: 10.2165/00003495-198530050-00002. Drugs. 1985. PMID: 3905336 Review. - Role of cephamycins in obstetrics and gynecology.
Sweet RL. Sweet RL. J Reprod Med. 1990 Nov;35(11 Suppl):1064-9. J Reprod Med. 1990. PMID: 2277374 Review.
Cited by
- Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults.
Wong PF, Gilliam AD, Kumar S, Shenfine J, O'Dair GN, Leaper DJ. Wong PF, et al. Cochrane Database Syst Rev. 2005 Apr 18;2005(2):CD004539. doi: 10.1002/14651858.CD004539.pub2. Cochrane Database Syst Rev. 2005. PMID: 15846719 Free PMC article. Review. - Piperacillin/tazobactam in the treatment of polymicrobial infections.
Gorbach SL. Gorbach SL. Intensive Care Med. 1994 Jul;20 Suppl 3:S27-34. doi: 10.1007/BF01745248. Intensive Care Med. 1994. PMID: 7962986 Review. - Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections.
Falagas ME, Barefoot L, Griffith J, Ruthazar R, Snydman DR. Falagas ME, et al. Eur J Clin Microbiol Infect Dis. 1996 Dec;15(12):913-21. doi: 10.1007/BF01690508. Eur J Clin Microbiol Infect Dis. 1996. PMID: 9031873 - The life and times of the Enterococcus.
Murray BE. Murray BE. Clin Microbiol Rev. 1990 Jan;3(1):46-65. doi: 10.1128/CMR.3.1.46. Clin Microbiol Rev. 1990. PMID: 2404568 Free PMC article. Review. - In Vitro Activity of Cefotetan against ESBL-Producing Escherichia coli and Klebsiella pneumoniae Bloodstream Isolates from the MERINO Trial.
Stewart AG, Cottrell K, Henderson A, Vemuri K, Bauer MJ, Paterson DL, Harris PNA. Stewart AG, et al. Microbiol Spectr. 2021 Sep 3;9(1):e0022621. doi: 10.1128/Spectrum.00226-21. Epub 2021 Jul 7. Microbiol Spectr. 2021. PMID: 34232101 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical